1. Product Overview
2. Research Methodology
3. Impact of COVID-19
on Global Alopecia Treatment Market
4.
Executive Summary
5. Voice of Customer
6. Global Alopecia Treatment Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1. By Disease Type (Androgenic Alopecia, Alopecia Areata, Ciatricial
Alopecia, Traction Alopecia, Alopecia Totalis)
6.2.2. By Gender (Male, Female)
6.2.3. By Route of Administration (Topical, Oral, Injectable)
6.2.4. By End User (Hospitals, Dermatologic and Trichology
Clinics, Home Care Settings, Aesthetic Clinics)
6.2.5. By Distribution Channel (Hospitals, Retail Pharmacies,
Online Pharmacies)
6.2.6. By Company (2021)
6.2.7.
By Region
6.3.
Product Market Map
7. North America Alopecia Treatment Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1.
By Disease Type
7.2.2.
By Gender
7.2.3.
By Route of Administration
7.2.4.
By End User
7.2.5.
By Distribution Channel
7.2.6.
By Country (United States; Canada; Mexico)
7.3.
North America: Country Analysis
7.3.1.
United States Alopecia Treatment
Market
Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Disease Type
7.3.1.2.2.
By Gender
7.3.1.2.3.
By Route of Administration
7.3.1.2.4.
By End User
7.3.1.2.5.
By Distribution Channel
7.3.2.
Canada Alopecia Treatment
Market
Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Disease Type
7.3.2.2.2.
By Gender
7.3.2.2.3.
By Route of Administration
7.3.2.2.4.
By End User
7.3.2.2.5.
By Distribution Channel
7.3.3.
Mexico Alopecia Treatment
Market
Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Disease Type
7.3.3.2.2.
By Gender
7.3.3.2.3.
By Route of Administration
7.3.3.2.4.
By End User
7.3.3.2.5.
By Distribution Channel
8. Europe Alopecia Treatment Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
By Disease Type
8.2.2.
By Gender
8.2.3.
By Route of Administration
8.2.4.
By End User
8.2.5.
By Distribution Channel
8.2.6.
By Country (France; Germany; UK; Italy; Spain)
8.3.
Europe: Country Analysis
8.3.1.
France Alopecia Treatment
Market
Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Disease Type
8.3.1.2.2.
By Gender
8.3.1.2.3.
By Route of Administration
8.3.1.2.4.
By End User
8.3.1.2.5.
By Distribution Channel
8.3.2.
Germany Alopecia Treatment
Market
Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Disease Type
8.3.2.2.2.
By Gender
8.3.2.2.3.
By Route of Administration
8.3.2.2.4.
By End User
8.3.2.2.5.
By Distribution Channel
8.3.3.
United Kingdom Alopecia Treatment
Market
Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Disease Type
8.3.3.2.2.
By Gender
8.3.3.2.3.
By Route of Administration
8.3.3.2.4.
By End User
8.3.3.2.5.
By Distribution Channel
8.3.4.
Italy Alopecia Treatment
Market
Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Disease Type
8.3.4.2.2.
By Gender
8.3.4.2.3.
By Route of Administration
8.3.4.2.4.
By End User
8.3.4.2.5.
By Distribution Channel
8.3.5.
Spain Alopecia Treatment
Market
Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Disease Type
8.3.5.2.2.
By Gender
8.3.5.2.3.
By Route of Administration
8.3.5.2.4.
By End User
8.3.5.2.5.
By Distribution Channel
9. Asia-Pacific Alopecia Treatment Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1.
By Disease Type
9.2.2.
By Gender
9.2.3.
By Route of Administration
9.2.4.
By End User
9.2.5.
By Distribution Channel
9.2.6. By Country (China; India; Japan; South Korea; Australia)
9.3.
Asia Pacific: Country Analysis
9.3.1.
India Alopecia Treatment
Market
Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Disease Type
9.3.1.2.2.
By Gender
9.3.1.2.3.
By Route of Administration
9.3.1.2.4.
By End User
9.3.1.2.5.
By Distribution Channel
9.3.2.
China Alopecia Treatment
Market
Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Disease Type
9.3.2.2.2.
By Gender
9.3.2.2.3.
By Route of Administration
9.3.2.2.4.
By End User
9.3.2.2.5.
By Distribution Channel
9.3.3.
Japan Alopecia Treatment
Market
Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Disease Type
9.3.3.2.2.
By Gender
9.3.3.2.3.
By Route of Administration
9.3.3.2.4.
By End User
9.3.3.2.5.
By Distribution Channel
9.3.4.
South Korea Alopecia Treatment
Market
Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Disease Type
9.3.4.2.2.
By Gender
9.3.4.2.3.
By Route of Administration
9.3.4.2.4.
By End User
9.3.4.2.5.
By Distribution Channel
9.3.5.
Australia Alopecia Treatment
Market
Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Disease Type
9.3.5.2.2.
By Gender
9.3.5.2.3.
By Route of Administration
9.3.5.2.4.
By End User
9.3.5.2.5.
By Distribution Channel
10. Middle East and
Africa Alopecia Treatment Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1.
By Disease Type
10.2.2.
By Gender
10.2.3.
By Route of Administration
10.2.4.
By End User
10.2.5.
By Distribution Channel
10.2.6.
By Country (UAE; Saudi Arabia; South Africa)
10.3.
MEA: Country Analysis
10.3.1.
South Africa Alopecia Treatment
Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Disease Type
10.3.1.2.2.
By Gender
10.3.1.2.3.
By Route of Administration
10.3.1.2.4.
By End User
10.3.1.2.5.
By Distribution Channel
10.3.2.
Saudi Arabia Alopecia Treatment
Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Disease Type
10.3.2.2.2.
By Gender
10.3.2.2.3.
By Route of Administration
10.3.2.2.4.
By End User
10.3.2.2.5.
By Distribution Channel
10.3.3.
UAE Alopecia Treatment
Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Disease Type
10.3.3.2.2.
By Gender
10.3.3.2.3.
By Route of Administration
10.3.3.2.4.
By End User
10.3.3.2.5.
By Distribution Channel
11. South America Alopecia Treatment Market Outlook
11.1.
Market Size & Forecast
11.1.1.
By Value
11.2.
Market Share & Forecast
11.2.1.
By Disease Type
11.2.2.
By Gender
11.2.3.
By Route of Administration
11.2.4.
By End User
11.2.5.
By Distribution Channel
11.2.6.
By Country (Brazil; Argentina; Colombia)
11.3.
South America: Country Analysis
11.3.1.
Brazil Alopecia Treatment Market Outlook
11.3.1.1.
Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2.
Market Share & Forecast
11.3.1.2.1.
By Disease Type
11.3.1.2.2.
By Gender
11.3.1.2.3.
By Route of Administration
11.3.1.2.4.
By End User
11.3.1.2.5.
By Distribution Channel
11.3.2.
Argentina Alopecia Treatment Market Outlook
11.3.2.1.
Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2.
Market Share & Forecast
11.3.2.2.1.
By Disease Type
11.3.2.2.2.
By Gender
11.3.2.2.3.
By Route of Administration
11.3.2.2.4.
By End User
11.3.2.2.5.
By Distribution Channel
11.3.3.
Colombia Alopecia Treatment Market Outlook
11.3.3.1.
Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2.
Market Share & Forecast
11.3.3.2.1.
By Disease Type
11.3.3.2.2.
By Gender
11.3.3.2.3.
By Route of Administration
11.3.3.2.4.
By End User
11.3.3.2.5.
By Distribution Channel
12. Market Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market Trends &
Developments
14. Competitive
Landscape
14.1.
Competition Outlook
14.2.
Global Players Profiled (Leading Companies)
14.2.1. Aclaris Therapeutics Inc.
14.2.2. Concert
Pharmaceuticals Inc.
14.2.3. Daiichi Sankyo Inc.
14.2.4. GlaxoSmithKline PLC
14.2.5. Johnson &
Johnson Inc.
14.2.6. Merck & Co. Inc.
14.2.7. Sun Pharmaceuticals
Industries Ltd.
14.2.8. Teva Pharmaceutical
Industries Ltd.
14.2.9. Dr. Reddy’s
Laboratories Ltd.
14.2.10.
Cipla Ltd.
14.2.11.
Histogen Inc.
14.2.12.
Pfizer Inc.
14.2.13.
Eli Lilly and Company Ltd.
14.2.14.
Bioniz Therapeutics Inc.
14.2.15.
Reistone Biopharma Company Limited
15. Strategic
Recommendations